Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: mRNA vaccine

Posted on February 20, 2021February 20, 2021

Proving variant-specific efficacy will be a logistic nightmare, very expensive: Gagandeep Kang

What are the main challenges in developing and testing booster vaccine doses to address the new variants? Each variant (and many more beyond the first three that have been widely…

Continue Reading
Posted on February 19, 2021February 19, 2021

Pfizer vaccine can be stored at -15 to -25 degree C for two weeks

On December 11, 2020 when the U.S. FDA approved the vaccine for emergency use, the storage temperature stipulated was -60 to -80 degree C. The labels for the vaccine too…

Continue Reading
Posted on January 3, 2021

Why people with prior SARS-CoV-2 infection still need to be vaccinated

Since vaccine shortage is expected to last at least for a few months, it may seem appealing to delay or avoid vaccinating those who have been naturally infected. But does…

Continue Reading
Posted on January 2, 2021

UK uses an untested strategy to rapidly but partially protect people at risk

With the virus running amok in the country and vaccines in short-supply, the U.K. is attempting an untested strategy of delaying the second dose of both AstraZeneca and Pfizer vaccine even in the absence of data from large trials. The intent is to rapidly but partially protect more individuals who are at risk.

Continue Reading
Posted on December 19, 2020

COVID-19: Ethical challenges of vaccinating people with comorbidities

Unlike in other groups, national databases of people with comorbidities are not available. However, though not comprehensive, since 2010, State governments have been conducting population-based district level screening to detect…

Continue Reading
Posted on December 12, 2020

Can COVID-19 vaccines with EUA be used at the population level?

Meanwhile, the Indian government has spelt out four high-risk groups — healthcare workers, frontline workers, those over 50 years of age and those aged below 50 years but with co-morbidities…

Continue Reading
Posted on December 11, 2020

By putting the vaccine approval on hold for want of data, DCGI has underscored its priorities

The greatly reassuring decision to seek additional safety and immunogenicity data from the Pune-based Serum Institute of India and Hyderabad’s Bharat Biotech underlines the regulator’s priorities even for emergency use…

Continue Reading
Posted on December 8, 2020December 8, 2020

Transparency in COVID-19 vaccine trials vital to gain public trust

Unlike Pfizer, AstraZeneca, which is carrying out the phase-3 trials of the Oxford vaccine in four countries, is yet to secure a nod from any of the regulatory agencies despite…

Continue Reading

Posts navigation

Page 1 Page 2 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,656 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • Vaccinate all above 45 years to avoid vaccine inequities February 26, 2021
  • People above 45 years with comorbidities will need doctor certificate, says task force member February 25, 2021
  • Are the variants causing a spike in cases in India? February 24, 2021
  • Covaxin has only 10% takers nationally; less than 1% uptake in 12 States, Union Territories February 22, 2021
  • Daily vaccination rate will soon increase exponentially, says task force member February 21, 2021

Most Read Posts

  • People above 45 years with comorbidities will need doctor certificate, says task force member
  • Are the variants causing a spike in cases in India?
  • Vaccinate all above 45 years to avoid vaccine inequities
  • UGC’s revised white list has 71 active predatory journals
  • UGC removes 4,305 journals from White list, including the Lancet Public Health
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • ICMR-NICED scientist has 16 papers with duplicated, manipulated images
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,656 other followers

Archives

Cancel

 
Loading Comments...
Comment
    ×